Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Mateon Therapeutics
Mateon Therapeutics
Industry · 14 registered clinical trials.
Status
Trial
Phase
Started
Completed
A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 Subjects
Covid19
Phase 4
2020-09-30
Terminated
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovaria
Platinum Resistant Ovarian Cancer
Phase 2 / Phase 3
2016-06-01
Unknown
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML a
Acute Myelogenous Leukemia, Myelodysplastic Syndromes
Phase 1 / Phase 2
2015-10-01
Withdrawn
Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer
Anaplastic Thyroid Cancer
Phase 3
2015-03-01
Completed
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Neuroendocrine Tumors
Phase 2
2014-12-01
Completed
A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Bi
Neuroendocrine Tumors
Phase 2
2014-09-01
Completed
Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculop
Polypoidal Choroidal Vasculopathy
Phase 2
2009-07-01
Completed
Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hep
Neoplasm Metastasis
Phase 1
2009-07-01
Completed
A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer
Tumors
Phase 2
2008-03-01
Terminated
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
Anaplastic Thyroid Cancer
Phase 2 / Phase 3
2007-08-01
Completed
Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With
Tumors
Phase 1
2006-09-01
Completed
Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients Wi
Solid Tumors
Phase 1
2005-07-01
Completed
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
Cancer, Tumor
Phase 2
2005-03-01
Completed
Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization S
Choroidal Neovascularization, Myopia, Degenerative
Phase 2
2005-03-01